Sennosides and senna labelling requirements

9 August 2021Labelling of products containing senna or sennosides must accurately reflect the active substance they contain.

Safety in lactation: Laxatives

25 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bulk-forming laxatives Bulk-forming laxatives are not…

Memo: Drug interactions with senna or salbutamol increasing the risk of torsade de pointes

7 February 2018This memo for prescribers and pharmacy staff has been produced in response to questions from primary care prescribers and pharmacists concerned about seemingly innocuous drug combinations…
Search Articles

Medicine Compliance Aid Stability


Tablets 7.5mg
A1 · Amber 1Stability data is available in an alternative container (not CAs) that may be extrapolated to support storage in CAs.
Airtight container
Protect from moisture
Protect from light and moisture.
22 February 2013

SenokotForum Health Products Ltd

Forum Health Products Ltd
Tablets 7.5mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Protect from light
Protect from moisture
Protect from light and moisture.
22 February 2013

Lactation Safety Information

Bisacodyl; Glycerol (rectal); Sodium picosulfate
Possible diarrhoea or loose stools, but not noticed in controlled studies. Active ingredient not detected in breast milk
Use standardised senna preparations and for short periods
Used in infants >1 month
31 July 2020